Galapagos NV
GLPG
#5074
Rank
โ‚น179.78 B
Marketcap
โ‚น2,677
Share price
0.00%
Change (1 day)
-5.48%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): -โ‚น37.14

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น39.33. In 2025 the company made an earnings per share (EPS) of โ‚น552.28 an increase over its 2024 EPS that were of โ‚น112.51.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น37.14-106.73%
2025โ‚น552.28390.86%
2024โ‚น112.51-67.16%
2023โ‚น342.57-199.64%
2022-โ‚น343.8099.03%
2021-โ‚น172.74-68.98%
2020-โ‚น556.89-298.06%
2019โ‚น281.17-554.64%
2018-โ‚น61.85-77.18%
2017-โ‚น271.04-326.21%
2016โ‚น119.82-134.19%
2015-โ‚น350.44-371.34%
2014โ‚น129.15-445.98%
2013-โ‚น37.3332.88%
2012-โ‚น28.09-82.07%
2011-โ‚น156.71-817.9%
2010โ‚น21.8312.73%
2009โ‚น19.36-120.79%
2008-โ‚น93.12-37.67%
2007-โ‚น149.4139.64%
2006-โ‚น107.0028.17%
2005-โ‚น83.486.25%
2004-โ‚น78.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น843.23-2,244.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น348.36-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น198.56-604.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น247.10-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น345.11-977.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น670.94-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น375.17-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚น346.57-981.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น132.26-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel